Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$100,896
New position
Shares Held
1,072
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Derivatives in INCY
reported options exposure · as of Mar 31, 2026CallValue
$291,772
CallShares
3,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026HUB Investment Partners, LLC holds $2,329,592 across 7 Biotechnology names. INCY ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,180 | $911,715 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,829 | $816,721 | |
| 3 | TECH |
BIO-TECHNE Corp
|
4,023 | $210,241 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
2,934 | $139,570 | |
| 5 | INCY |
Incyte Corp
This page
|
1,072 | $100,896 | |
| 6 | ALT |
Altimmune, Inc.
|
30,218 | $93,071 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
18,690 | $57,378 |
All Filings in INCY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,896 | 1,072 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $291,772 | 3,100 | Call | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||